Skip to main content

Table 2 Changes in liver functions of liver cirrhotic patients with TIPS treatment

From: Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment

 

Baseline

1 year

2 years

3 years

4 years

5 years

(n = 704)

(n = 638)

(n = 587)

(n = 530)

(n = 485)

(n = 445)

ALT (U/L)

51 ± 28

47 ± 19

55 ± 31

52 ± 21

58 ± 20

55 ± 18

T-BIL (μmol/L)

29.2 ± 19.7

34.8 ± 20.1

32.9 ± 21.8

35.9 ± 20.8

34.6 ± 19.7

27.6 ± 18.0

Albumin (g/L)

28.9 ± 10.2

29.1 ± 11.7

30.0 ± 9.8

28.7 ± 8.2

29.7 ± 9.2

30.1 ± 12.8

Blood ammonia (μmol/L)

64.7 ± 25.9

87.6 ± 27.1 ##

81.5 ± 19.8 ##

76.2 ± 20.5 ##

78.2 ± 21.2 #

71.0 ± 11.6

PTA (%)

56.8 ± 12.5

37.8 ± 9.1 #

51.4 ± 8.7

49.2 ± 11.0

50.1 ± 10.2

50.8 ± 8.9

INR

1.36 ± 0.23

1.90 ± 0.46 #

1.48 ± 0.51

1.50 ± 0.49

1.50 ± 0.44

1.47 ± 0.38

Stiffness (KPa)

18.6 ± 10.7

17.6 ± 9.8

17.9 ± 12.7

16.8 ± 8.6

16.7 ± 9.1

17.1 ± 10.2

  1. #P < 0.05, ## P < 0.01 compared with baseline, Dunn’s multiple comparison test